Abstract
Conducting intervention studies in Africa, where medicines supply for chronic conditions is inequitable and patchy, raises major ethical issues.
Here we discuss what should the ethical approach be for a research programme in terms of provision of a steady and sustainable supply of medicines for patients with diabetes and hypertension.
Here we discuss what should the ethical approach be for a research programme in terms of provision of a steady and sustainable supply of medicines for patients with diabetes and hypertension.
Original language | English |
---|---|
Article number | e002193 |
Journal | BMJ Global Health |
Volume | 5 |
Issue number | 7 |
Early online date | 6 Jul 2020 |
DOIs | |
Publication status | Published - 6 Jul 2020 |
Profiles
-
Max Bachmann
- Norwich Medical School - Professor of Health Services Research
- Norwich Institute for Healthy Aging - Member
- Population Health - Member
- Norwich Epidemiology Centre - Member
- Health Services and Primary Care - Member
Person: Research Group Member, Research Centre Member, Academic, Teaching & Research